Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations-Reference-Cited by-同舟云学术

Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations

Published:2019-01-30 Issue:1 Volume:6 Page:31-41
ISSN:2214-3599
Container-title:Journal of Neuromuscular Diseases
language:
Short-container-title:JND

Author:

Bowden Sasigarn A.¹,Connolly Anne M.²,Kinnett Kathi³,Zeitler Philip S.⁴

Affiliation:

1. Division of Endocrinology, Department of Pediatrics, Nationwide Children’s Hospital/The Ohio State University College of Medicine, Columbus, Ohio, USA

2. Department of Neurology, Washington University School of Medicine in Saint Louis, St. Louis, Missouri, USA

3. Parent Project Muscular Dystrophy, Hackensack, New Jersey, USA

4. Department of Pediatrics, Division of Endocrinology, University of Colorado School of Medicine, Aurora, Colorado, USA

Publisher

IOS Press

Subject

Clinical Neurology,Neurology

Reference45 articles.

1. Duchenne muscular dystrophy Patterns of clinical progression and effects of supportive therapy;Brooke;Neurology,1989

2. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy;Mah;Neuromuscular Disorders,2014

3. Population frequencies of inherited neuromuscular diseases–a world survey;Emery;Neuromuscular disorders: NMD,1991

4. Prevalence of Duchenne and Becker muscular dystrophies in the United States;Romitti;Pediatrics,2015

5. Evidence-based path to newborn screening for Duchenne muscular dystrophy;Mendell;Annals of Neurology,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severity of acute phase reaction in children receiving the first dose of zoledronic acid and the impact of the underlying condition: a cross-sectional study;Archives of Disease in Childhood;2024-05-31

2. Adrenocortical suppression in children with nephrotic syndrome treated with corticosteroids;Pediatric Nephrology;2024-01-23

3. Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy;The Journal of Clinical Endocrinology & Metabolism;2023-08-23

4. Adrenocortical suppression in children with nephrotic syndrome treated with corticosteroids;2023-08-18

5. Duchenne Muscular Dystrophy Fatigue Trajectories;Neuropediatrics;2023-05-26